ÂÜÀòÂÒÂ×

Emily Gaudiano is an accomplished professional in the field of chemical biology with a Ph.D. from Harvard University and a B.S. from Boston College. Currently serving as an Associate at SV Health Investors since May 2024, Emily previously held a similar position at MPM BioImpact. A member of the Leadership Team of the GSAS Harvard Biotech Club from January 2020 to May 2022, Emily co-directed the Engage Workshop series, focusing on skill development for academic scientists transitioning to industry careers. Emily's extensive research experience includes a Ph.D. program at Harvard Medical School, where investigations centered on cancer-related intracellular signaling mechanisms, as well as prior roles as a research technician at Dana-Farber Cancer Institute, biology intern at Constellation Pharmaceuticals, and scientific editor.